Concepedia

Stacy L. Moulder

SL

Statistics

Publications

99

Citations

6.6K

H-Index

39

Active since

2001

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of California San Diego

Baylor College of Medicine

Moffitt Cancer Center

The University of Texas Southwestern Medical Center

Stacy L. Moulder is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and molecular oncology.

Publications per year

2001–2024

99

Publications

99

Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype

W. Fraser Symmans, Caimiao Wei, Rebekah Gould et al. · Journal of Clinical Oncology · 2017 · 718 citations · Full text

Medicine, Oncology, Breast Oncology +16

Adaptive Randomization of Veliparib–Carboplatin Treatment in Breast Cancer

Hope S. Rugo, Olufunmilayo I. Olopade, Angela DeMichele et al. · New England Journal of Medicine · 2016 · 555 citations · Full text

Medicine, Oncology, Pharmacology +13

Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo.

Stacy L. Moulder, F. Michael Yakes, Senthil K. Muthuswamy et al. · PubMed · 2001 · 549 citations

Medicine, Oncology, Pharmacology +16

Adaptive Randomization of Neratinib in Early Breast Cancer

John W. Park, Minetta C. Liu, Douglas Yee et al. · New England Journal of Medicine · 2016 · 460 citations · Full text

Medicine, Oncology, Pharmacology +17

Association of Event-Free and Distant Recurrence–Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer

Douglas Yee, Angela DeMichele, Christina Yau et al. · JAMA Oncology · 2020 · 225 citations · Full text

Medicine, Oncology, Breast Oncology +15

1–5 of 99